Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Vaping
Interventions: Acted-Out Narrative Ads, Non-Acted-Out Narrative Testimonial Ads, Neutral Control Videos; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 13 Years to 20 Years
Enrollment: 1,910 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Fairfield, Connecticut • Chapel Hill, North Carolina

Conditions: Gynaecologic Cancer
Interventions: Nurse Led Sexual Health Clinical Program Intervention; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HIV Infections
Interventions: SEPA+PrEP Women; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Anhedonia, Depression
Interventions: ReLIT (Reward Learning Intensive Training), ST (Sham Training); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: San Diego, California

Conditions: Spine Surgery, Intraoperative Hypotension, Tissue Perfusion
Interventions: Phenylephrine hydrochloride infusion, Norepinephrine bitartrate infusion; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Acute Brain Injury, Traumatic Brain Injury, Intracranial Hemorrhage, Hydrocephalus, Stroke, Brain Neoplasm, Hypoxia-Ischemia, Brain
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 2 Years to 17 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Cholecystitis, Acute
Interventions: Not listed
Lead sponsor: European Society for Trauma and Emergency Surgery; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Risk
Interventions: urine-based self-test, urine-based clinic test; Diagnostic Test
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
Interventions: Medical Device Usage and Evaluation, Tirzepatide; Other · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Chicago, Illinois • Houston, Texas

Conditions: Neuropathic Pain, Chronic Pain
Interventions: Ultrasound, Sham (No Treatment); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Metastatic Triple Negative Breast Cancers
Interventions: Sacituzumab tirumotecan; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy
Interventions: Nadi Shuddhi, Shoonya Meditation; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 25 Years to 60 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Interventions: Low-Dose Naltrexone, 1.5mg, Low-Dose Naltrexone, 3.0mg, Low-Dose Naltrexone, 4.5mg, Low-Dose Naltrexone, 6.0mg; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Anxiety, Depression - Major Depressive Disorder, Burnout, Insomnia, Resilience, Feasibility, Acceptability
Interventions: Transcendental Meditation; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Asthma, Asthma Chronic, Asthma Severe Persistent With Exacerbation, Asthma Moderate Persistent With Exacerbation
Interventions: PARTICS using a single ICS add on, MART; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 4,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 6
States / cities: New Haven, Connecticut • Boston, Massachusetts • St Louis, Missouri + 3 more

Conditions: Type 2 Diabetes, Liver Disease
Interventions: Behavioral Treatment; Device
Lead sponsor: SIPPA Solutions INC; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Jamaica, New York

Conditions: Cataract
Interventions: PureSee IOL; Device
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 40 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Amputation; Lower Extremity, Pain, Persistent Postsurgical
Interventions: Surgical Implantation; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Idiopathic Subglottic Tracheal Stenosis
Interventions: Voice Biomarker Screening Too; Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Frontal Fibrosing Alopecia
Interventions: Delgocitinib; Drug
Lead sponsor: Maryanne Makredes Senna; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Colorectal Cancer Control and Prevention
Interventions: Decision Tool; Behavioral
Lead sponsor: Kathryn Martinez; Other
Eligibility: 76 Years and older
Enrollment: 15,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Mild Cognitive Impairment
Interventions: Project 2, Phase 2: Intelligent Adaptive System; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 60 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Tallahassee, Florida • Champaign, Illinois • New York, New York

Conditions: Amputation Pain
Interventions: Strong But Comfortable TENS, Just Perceptible TENS; Device
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Energy Deficiency Due to Short-term Fasting, Hormonal Contraception
Interventions: Energy Deficiency of approximately ~250 kcal/day; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Evaluating Narrative Vaping Prevention Video Ads for Adolescents and Young Adults

Improving Sexual Health in Gynecological Cancer Patients

SEPA+PrEP-Women Pilot Trial for HIV Prevention Among Women at Risk for HIV

Neurocomputational Training to Improve Reward Responsiveness in Veterans With Anhedonia

Superiority of Phenylephrine Versus Norepinephrine in Complex Spine Surgery (SPiNeS)

Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury

SnapChole: An International, Time-Bound Prospective Platform Study of Management Strategies and Outcomes in Acute Calculous Cholecystitis

Supporting Health and Empowerment Through Contingency Management and Affect Regulation

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Ultrasound for Peripheral Nerve Modulation

Sac-TMT for Active TNBC Brain Metastases

Meditation and Yogic Breathing-driven Modulation of Neurofluid Coupling and Brain Clearance

Low-Dose Naltrexone For ME/CFS: Dose-Finding

Transcendental Meditation Intervention to Reduce Burnout and Enhance Resilience Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents

Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk

A Prospective, Single-Arm Clinical Evaluation of Visual, Refractive, and Patient-Reported Outcomes Following Bilateral Implantation of the TECNIS PureSee™ Extended Depth of Focus Intraocular Lens

Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI

Voice Quality Analysis of Patients With Laryngotracheal Stenosis

Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)

Life Expectancy-informed Colorectal Cancer Screening

Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2

Stimulation for Amputation Pain Management

Energy Deficiency on Hormones in Contraceptive Users